… had the great opportunity to observe the administration of CAR-T cells, one of the highlights of her visit. She also visited … educational programmes. Research and hopefully observe CAR-T cells administration. The first half of my visit was …

… relapse C. Aplastic anemia D. Prolonged cytopenia after CAR-T cell infusion Expert opinion by Barbara Dreta : … disorder, rheumatologic disease and specific therapy. CAR-T cell treatment can cause cytokine release syndrome …

… use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT Jakob R. Passweg et al   … collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study Mirko …

… Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune … the EBMT Simona Iacobelli et al   ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling …

… III: Key Note Lecture Improving outcomes of therapy with CAR T cells. S. Riddell In the first part of the lecture the differences in the signaling domains of the different CAR T cells are explained. Most used signaling strategies are … Reports of the 1st European CAR T Cell Meeting 14-16 February 2019 - Paris, France …

… Plenary Session P4: New developments in the field of CAR T cell therapy Wednesday, March 17, 16:15 - 17:30, Auditorium … 1 This three-part plenary session on new developments in CAR therapy will be opened by Dr Marcela Maus of Harvard … EBMT 2021 Annual Meeting - New developments in CAR therapy …

… in Malaga, Spain. The exciting meeting on complications in CAR T-cell therapy took place in January 2025. …

… a joint meeting focusing on common research themes of CAR-T in multiple myeloma (MM). A keynote lecture was given by … results in patients with MM and that potentially moving CAR-T cells and bispecifics to earlier lines over the natural …

… Horgan, senior clinical research fellow in Paediatric BMT, CAR-T and stem cell gene therapy at Royal Manchester Children's … world with different resources and health systems, and a CAR-T roundtable discussion.”  “The second trainee session is …

… Garderet (Paris) there was a debate on the placement of CAR-T in the autoHCT algorithm for myeloma. Nico Gagelmann … France) gave a presentation on whether the advent of CAR-T for CLL would completely displace allo-HCT. Professor …